Curexo Inc Market Cap ($153.72 Million)
Market Cap & Net Worth: Curexo Inc (060280)
Curexo Inc market cap. Curexo Inc (KQ:060280) has a market capitalization of $153.72 Million (₩226.83 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17372 globally and #700 in its home market, demonstrating a -6.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curexo Inc's stock price ₩6800.00 by its total outstanding shares 33357300 (33.36 Million). Also see Curexo Inc (060280) cash conversion ratio for how efficiently the company converts equity into cash flow.
Curexo Inc Market Cap History (2015–2026)
Curexo Inc market cap history from 2015 to 2026. Data shows growth from $132.39 Million to $153.72 Million (1.42% CAGR). Check current stock price of Curexo Inc for real-time trading data and today's change.
Index Memberships
Curexo Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.08% | #251 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.08% | #251 of 1384 |
Weight: Curexo Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Curexo Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curexo Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 060280 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Curexo Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $132.39 Million | $27.53 Billion | -$9.40 Billion | 0.00x | N/A |
| 2016 | $111.29 Million | $30.06 Billion | $24.15 Billion | 0.00x | 0.00x |
| 2017 | $212.03 Million | $33.48 Billion | -$16.88 Billion | 0.01x | N/A |
| 2018 | $145.58 Million | $33.89 Billion | -$29.42 Billion | 0.00x | N/A |
| 2019 | $107.26 Million | $34.39 Billion | -$25.92 Billion | 0.00x | N/A |
| 2020 | $141.74 Million | $39.28 Billion | $416.63 Million | 0.00x | 0.34x |
| 2021 | $167.51 Million | $42.79 Billion | -$2.34 Billion | 0.00x | N/A |
| 2022 | $151.91 Million | $64.99 Billion | -$3.04 Billion | 0.00x | N/A |
| 2023 | $420.69 Million | $72.88 Billion | -$4.86 Billion | 0.01x | N/A |
| 2024 | $146.03 Million | $55.53 Billion | -$8.76 Billion | 0.00x | N/A |
Competitor Companies of 060280 by Market Capitalization
Companies near Curexo Inc in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Curexo Inc for a full breakdown of the balance sheet.
Key companies related to Curexo Inc by market ranking:
- Seouleaguer Co. Ltd (KQ:043710): Ranked #21265 globally with a market cap of $55.80 Million USD ( ₩82.35 Billion KRW).
- Gimat Magazacilik Sanayi ve Ticaret AS (IS:GMTAS): Ranked #31865 globally with a market cap of $11.04K USD ( TL493.01K TRY).
- Sparebanken Ost (OL:SPOG): Ranked #17363 globally with a market cap of $154.02 Million USD ( Nkr1.46 Billion NOK).
- Bjorn Borg AB (ST:BORG): Ranked #17364 globally with a market cap of $153.99 Million USD ( Skr1.43 Billion SEK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #21265 | Seouleaguer Co. Ltd | KQ:043710 | $55.80 Million | ₩2790.00 |
| #31865 | Gimat Magazacilik Sanayi ve Ticaret AS | IS:GMTAS | $11.04K | TL49.36 |
| #17363 | Sparebanken Ost | OL:SPOG | $154.02 Million | Nkr70.60 |
| #17364 | Bjorn Borg AB | ST:BORG | $153.99 Million | Skr56.90 |
Market Capitalization of Curexo Inc (2015–2026)
Market capitalization of Curexo Inc from 2015 to today. Between 2015 and today, Curexo Inc's market cap moved from $132.39 Million to $ 153.72 Million, with a yearly change of 1.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩153.72 Million | -47.53% |
| 2025 | ₩292.97 Million | +100.62% |
| 2024 | ₩146.03 Million | -65.29% |
| 2023 | ₩420.69 Million | +176.93% |
| 2022 | ₩151.91 Million | -9.31% |
| 2021 | ₩167.51 Million | +18.18% |
| 2020 | ₩141.74 Million | +32.14% |
| 2019 | ₩107.26 Million | -26.32% |
| 2018 | ₩145.58 Million | -31.34% |
| 2017 | ₩212.03 Million | +90.52% |
| 2016 | ₩111.29 Million | -15.93% |
| 2015 | ₩132.39 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Curexo Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $153.72 Million USD |
| MoneyControl | $153.72 Million USD |
| MarketWatch | $153.72 Million USD |
| marketcap.company | $153.72 Million USD |
| Reuters | $153.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Curexo Inc
Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more